Table 2.
Total person-month
|
Person-months with PI/NNRTI use
|
GEE regression on monthly PI/NNRTI use
|
||||
---|---|---|---|---|---|---|
N | % | N | % | OR | 95% CI | |
Total | 9,808 | 100.0 | 6,157 | 62.8 | – | – |
Antidepressant use in the previous montha | ||||||
Yes | 3,411 | 34.8 | 2,371 | 69.5 | 1.28** | [1.16,1.41] |
No | 6,397 | 65.2 | 3,786 | 59.2 | – | – |
Sexa | ||||||
Male | 5,299 | 54.0 | 3,272 | 61.8 | – | – |
Female | 4,509 | 46.0 | 2,885 | 64.0 | 1.13 | [0.91,1.41] |
Racea | ||||||
White | 2,765 | 28.5 | 1,851 | 66.9 | – | – |
African Americans | 4,785 | 49.3 | 2,955 | 61.8 | 0.71* | [0.53,0.95] |
Latinos | 2,162 | 22.3 | 1,310 | 60.6 | 0.61** | [0.43,0.85] |
Age at primary diagnosisa | ||||||
18–29 | 1,315 | 13.4 | 738 | 56.1 | – | – |
30–39 | 5,366 | 54.7 | 3,310 | 61.7 | 1.23 | [0.89,1.71] |
40–45 | 2,178 | 22.2 | 1,440 | 66.1 | 1.49* | [1.01,2.21] |
46 and above | 949 | 9.7 | 669 | 70.5 | 1.97** | [1.22,3.17] |
Mode of transmissiona | ||||||
Non-IDUs | 2,569 | 26.2 | 1,675 | 65.2 | – | – |
Injection drug users | 6,052 | 61.7 | 3,716 | 61.4 | 0.77+ | [0.59,1.02] |
Missing | 1,187 | 12.1 | 766 | 64.5 | 0.80 | [0.55,1.18] |
County of residencea | ||||||
High prevalence | 7,202 | 73.4 | 4,697 | 65.2 | 1.80** | [1.37,2.37] |
Other | 2,606 | 26.6 | 1,460 | 56.0 | – | – |
Waiver statusa | ||||||
ACCAP | 2,102 | 21.4 | 1,445 | 68.7 | 1.46* | [1.07,1.99] |
Non-ACCAP | 7,706 | 78.6 | 4,712 | 61.2 | – | – |
Medicare Coveragea | ||||||
Yes | 4,024 | 41.0 | 2,579 | 64.1 | 0.94 | [0.74,1.20] |
No | 5,784 | 59.0 | 3,578 | 61.9 | – | – |
Year of diagnosis | ||||||
1991–1992 | 2,741 | 28.0 | 1,706 | 62.2 | – | – |
1993–1994 | 4,703 | 48.0 | 2,994 | 63.7 | 1.04 | [0.79,1.36] |
1995–1996 | 2,364 | 24.1 | 1,457 | 61.6 | 0.94 | [0.69,1.28] |
Note: Based on New Jersey Medicaid participants who were aged 18 and over at the time of receiving AIDS diagnosis, diagnosed with AIDS from 1990 through March 1996, continuously enrolled in Medicaid fee-for-service program between January 1996 and December 1998, diagnosed with depression, and had at least one PI/NNRTI filled during this period. Superscript a denotes significant subgroup difference (P <.05) in overall rate of monthly PI/NNRTI use using Chi-square statistics.**, * and + denote significant effect at 1%, 5%, and 10% levels, respectively, in the GEE regression on monthly PI/NNRTI use